Arthrex Burr Recall: Excessive Heat Risk During Use
Arthrex recalls oval surgical burrs (AR-8550OBT) that may overheat during arthroscopic procedures. Affected units have specific lot numbers and expiration dates.
Use caution until it’s fixed
Devices may generate excessive heat during use.
Contact the company
What happened, in plain English
Arthrex is recalling oval surgical burrs that could overheat during use. This risk could cause burns or tissue damage if the burr gets too hot while being used in arthroscopic procedures. Read more at govinfonow.com/recall/69122-arthrex-burr-recall-excessive-heat-risk-during-use.
Source Summary by GovInfoNow · govinfonow.com/recall/69122-arthrex-burr-recall-excessive-heat-risk-during-use · Updated August 20, 2026 · FDA enforcement record: FDA #Z-1206-2019
Cite this page
“Arthrex Burr Recall: Excessive Heat Risk During Use.” GovInfoNow, updated August 20, 2026. https://govinfonow.com/recall/69122-arthrex-burr-recall-excessive-heat-risk-during-use. Based on FDA recall #Z-1206-2019 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-1206-2019%22&limit=1).
Why it’s dangerous
These burrs can generate excessive heat when used during arthroscopic surgery. Overheating could cause burns to tissues or damage the surgical site. The risk is higher during prolonged use or when the burr is not properly cooled.
Who’s affected
Surgical professionals using these burrs for arthroscopic procedures are most at risk. Patients undergoing surgery with these devices may also be affected.
How to tell if you have this one
Check for the model number AR-8550OBT on the burr. Affected units have lot numbers 10211276 (expiring 4/30/2023) or 10202784 (expiring 3/31/2023).
- Brand
Arthrex- Category
Medical device
What to do — step by step
Check Product Lot Number
Look for lot numbers 10211276 or 10202784 on the burr packaging or label.
Where it went and when
Where it was distributed
Distributed nationwide and abroad; the notice names 33 states.
FDA distribution: “Worldwide Distribution: US (nationwide) to states of: AL, AZ, CA, CO, DC, FL, GA, HI, IA, ID, IL, KY, LA, MA, MD, MI, MN, MO, NC, ND, NH, NY, OH, OK, PA, RI, SC, SD, TN, TX, VA, WA, WI, and WY; and to countries of: Germany, Brazil and…” States read from FDA’s own wording; “not listed” means the notice does not name it.
Named in the notice: Alabama, Arizona, California, Colorado, District of Columbia, Florida, Georgia, Hawaii, Idaho, Illinois, Iowa, Kentucky, Louisiana, Maryland, Massachusetts, Michigan, Minnesota, Missouri, New Hampshire, New York, North Carolina, North Dakota, Ohio, Oklahoma, Pennsylvania, Rhode Island, South Carolina, South Dakota, Tennessee, Texas, Virginia, Washington, Wisconsin, Wyoming.
Recall timeline
FDA terminated this recall 4.6 years after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest medical device recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #Z-1206-2019 (January 14, 2019) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-1206-2019 to see it in context.
- Plain-language summary written by qwen3:4b on August 20, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.